NCT06393309View on ClinicalTrials.gov

Levetiracetam Versus Valproate in Idiopathic Generalized Epilepsy

CompletedOBSERVATIONAL
Enrollment

169

Participants

Timeline

Start Date

September 3, 2022

Primary Completion Date

March 19, 2024

Study Completion Date

March 19, 2024

Conditions
Treatment of Idiopathic Generalized Epilepsy
Interventions
DRUG

Levetiracetam

Patients with idiopathic generalized epilepsy who were under treatment with levetiracetam

DRUG

Sodium valproate

Patients with idiopathic generalized epilepsy who were under treatment with valproate

Trial Locations (1)

4815837477

Bu Ali Sina Hospital, Sari

All Listed Sponsors
lead

Mazandaran University of Medical Sciences

OTHER